ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 170 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,711,826 | -26.5% | 116,514 | -15.5% | 0.49% | -47.0% |
| Q4 2022 | $6,411,107 | +0.5% | 137,814 | +12.0% | 0.92% | +6.1% |
| Q3 2022 | $6,381,000 | +35.0% | 123,014 | +23.0% | 0.87% | +17.6% |
| Q2 2022 | $4,727,000 | -67.2% | 100,000 | -50.6% | 0.74% | -60.4% |
| Q1 2022 | $14,413,000 | -39.4% | 202,485 | -36.4% | 1.86% | -22.0% |
| Q4 2021 | $23,801,000 | +129.7% | 318,275 | +74.5% | 2.38% | +47.6% |
| Q3 2021 | $10,362,000 | +1870.0% | 182,400 | +1486.1% | 1.62% | +478.9% |
| Q3 2020 | $526,000 | -8.8% | 11,500 | 0.0% | 0.28% | -15.2% |
| Q2 2020 | $577,000 | +5.9% | 11,500 | +8.5% | 0.33% | -48.1% |
| Q1 2020 | $545,000 | – | 10,600 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 476,042 | $45,472,000 | 12.29% |
| Stonepine Capital Management, LLC | 60,840 | $5,811,000 | 3.34% |
| ACUTA CAPITAL PARTNERS, LLC | 61,000 | $5,827,000 | 2.77% |
| Virtus ETF Advisers LLC | 10,634 | $1,016,000 | 2.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $5,827,000 | 2.15% |
| ARMISTICE CAPITAL, LLC | 372,000 | $35,533,000 | 1.94% |
| Matarin Capital Management, LLC | 209,403 | $20,002,000 | 1.46% |
| Monashee Investment Management LLC | 50,000 | $4,776,000 | 1.10% |
| Granahan Investment Management | 151,322 | $14,454,000 | 0.78% |
| ALGERT GLOBAL LLC | 13,186 | $1,260,000 | 0.72% |